Bio

Kirtan Pansari is a Managing Director in the firm’s strategic advisory business focused on the Chemicals sector and is based in Evercore’s London office. Kirtan has advised on over 30 strategic and financing transactions during his career, including advising KWS on the acquisition of Pop Vriend, UPL on the acquisition of Arysta, Carlyle on the acquisition of AkzoNobel Speciality Chemicals, Dupont on its asset exchange with FMC, Egeria on its sale of DenBraven to Arkema, Saudi Aramco on its acquisition of 50% in Arlanxeo, Bayer on their dual track exit of Covestro, Israel Corporation on the demerger and listing of Kenon, AkzoNobel on the sale of Building Adhesives to Sika, AkzoNobel on the public takeover of Schramm, Charterhouse on the sale of Lucite to Mitshubishi Rayon, Neochimiki on their sale to Carlyle, Statkraft on their asset swap with E.ON, Philips on their acquisition of Respironics, the merger of Gemplus and Axalto and Autonomy on their acquisition of both Verity and Zantaz. In addition, Kirtan has worked on a range of capital market transactions including Synthos on their HY financing and dividend recap, M&G on their financing of CorpusChristi, CVC on their HY financing of Parex, Permira on the LBO financing of CABB, Apollo on the LBO financing of Taminco, Ineos on various bond refinancings, Petronas on the consolidation, demerger and listing of Petronas Chemicals, and KKR, SilverLake, Bain, Apax and Alpinvest on their LBO financing of Philips Semiconductors (NXP). Before joining Evercore in 2015, Kirtan was a Director at Deutsche Bank in London in the Investment Banking division, where he worked for ten years, initially in the TMT and Structured Equity groups and subsequently in the Natural Resources group. Before Deutsche Bank, Kirtan was at Goldman Sachs in the Macroeconomics and Equity Portfolio Strategy team. Kirtan is a CFA Charterholder and has a BSc in Economics from LSE.